SCHEMBL6172298

SCHEMBL6172298

CCNc1cc(C(C)C2(C(C)c3ccnc(NCC)c3)NC(=O)N(c3ccc(SC(F)(F)F)c(Cl)c3)C2=O)ccn1

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 12/20 0.42
AR P10275 3/20 0.37
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174954 0.91 IGF1R (0.40) IGF1RARKMT2AMEN1TSHR
SCHEMBL6173106 0.88 IGF1R (0.48) IGF1RARKMT2A
SCHEMBL6173508 0.87 IGF1R (0.56) IGF1RAR
SCHEMBL17558394 0.87 AR (0.41) IGF1RARKMT2AMEN1TSHR
SCHEMBL6177138 0.85 AR (0.40) IGF1RARKMT2AMEN1TSHR
SCHEMBL6174561 0.80 IGF1R (0.40) IGF1RARKMT2ATSHR
SCHEMBL6169038 0.79 IGF1R (0.39) IGF1RARKMT2AMEN1TSHR
SCHEMBL6173711 0.77 IGF1R (0.59) IGF1R
SCHEMBL6176345 0.77 IGF1R (0.53) IGF1RAR
SCHEMBL6175543 0.76 IGF1R (0.56) IGF1RAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3188729-A1 CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS Genzyme Corporation (US) 2017-07-12 EP disclosed
WO-2016036796-A1 CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS GENZYME CORPORATION (US) 2016-03-10 WO disclosed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed